135 related articles for article (PubMed ID: 8158213)
21. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.
Muntoni F; Mateddu A; Cianchetti C; Marrosu MG; Clerk A; Cau M; Congiu R; Cao A; Melis MA
J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):26-31. PubMed ID: 8429320
[TBL] [Abstract][Full Text] [Related]
22. [Molecular pathology of Duchenne and Becker muscular dystrophy].
Sugita H
Rinsho Shinkeigaku; 1990 Dec; 30(12):1309-16. PubMed ID: 2099874
[TBL] [Abstract][Full Text] [Related]
23. Dystrophin characterization in BMD patients: correlation of abnormal protein with clinical phenotype.
Morandi L; Mora M; Confalonieri V; Barresi R; Di Blasi C; Brugnoni R; Bernasconi P; Mantegazza R; Dworzak F; Antozzi C
J Neurol Sci; 1995 Oct; 132(2):146-55. PubMed ID: 8543940
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of dystrophin test for patients with various neuromuscular diseases--immunofluorescence and immunoblot analyses of dystrophin abnormalities].
Ikeya K; Saito K; Yamauchi A; Kondo E; Komine S; Ikenaka H; Mishima M; Takahashi R; Harada T; Fukuyama Y
No To Hattatsu; 1993 Jul; 25(4):328-34. PubMed ID: 8338694
[TBL] [Abstract][Full Text] [Related]
25. [Muscular dystrophies detected by immunophenotyping and genotype analysis (mRNA and DNA)].
Lukás Z; Vojtísková M; Fajkusová L; Bednarík J; Kadanka Z; Hájek J; Hermanová M; Vohánka S; Vytopil M
Cesk Patol; 2001 Nov; 37(4):137-45. PubMed ID: 11813630
[TBL] [Abstract][Full Text] [Related]
26. Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects.
Mizuno Y; Nonaka I; Hirai S; Ozawa E
J Neurol Sci; 1993 Oct; 119(1):43-52. PubMed ID: 8246010
[TBL] [Abstract][Full Text] [Related]
27. Detection of dystrophin on two-dimensional gel electrophoresis.
Hori S; Sugiura H; Shimizu T; Hirabayashi T; Ohtani S; Yoshida M; Miyamoto K; Tanabe H
Biochem Biophys Res Commun; 1989 Jun; 161(2):726-31. PubMed ID: 2660791
[TBL] [Abstract][Full Text] [Related]
28. Duchenne phenotype with in-frame deletion removing major portion of dystrophin rod: threshold effect for deletion size?
Fanin M; Freda MP; Vitiello L; Danieli GA; Pegoraro E; Angelini C
Muscle Nerve; 1996 Sep; 19(9):1154-60. PubMed ID: 8761273
[TBL] [Abstract][Full Text] [Related]
29. Cardiac dystrophin abnormalities in Becker muscular dystrophy assessed by endomyocardial biopsy.
Maeda M; Nakao S; Miyazato H; Setoguchi M; Arima S; Higuchi I; Osame M; Taira A; Nomoto K; Toda H
Am Heart J; 1995 Apr; 129(4):702-7. PubMed ID: 7900621
[TBL] [Abstract][Full Text] [Related]
30. Dystrophin in skeletal muscle. I. Western blot analysis using a monoclonal antibody.
Nicholson LV; Davison K; Falkous G; Harwood C; O'Donnell E; Slater CR; Harris JB
J Neurol Sci; 1989 Dec; 94(1-3):125-36. PubMed ID: 2693617
[TBL] [Abstract][Full Text] [Related]
31. Clinical variability in Becker muscular dystrophy. Genetic, biochemical and immunohistochemical correlates.
Comi GP; Prelle A; Bresolin N; Moggio M; Bardoni A; Gallanti A; Vita G; Toscano A; Ferro MT; Bordoni A
Brain; 1994 Feb; 117 ( Pt 1)():1-14. PubMed ID: 8149204
[TBL] [Abstract][Full Text] [Related]
32. Improved diagnosis of Becker muscular dystrophy by dystrophin testing.
Hoffman EP; Kunkel LM; Angelini C; Clarke A; Johnson M; Harris JB
Neurology; 1989 Aug; 39(8):1011-7. PubMed ID: 2668783
[TBL] [Abstract][Full Text] [Related]
33. Dystrophin and nebulin in the muscular dystrophies.
Patel K; Voit T; Dunn MJ; Strong PN; Dubowitz V
J Neurol Sci; 1988 Nov; 87(2-3):315-26. PubMed ID: 3062133
[TBL] [Abstract][Full Text] [Related]
34. Dystrophin abnormalities in Duchenne and Becker dystrophy carriers: correlation with cytoskeletal proteins and myosins.
Mora M; Morandi L; Piccinelli A; Gussoni E; Gebbia M; Blasevich F; Dworzak F; Cornelio F
J Neurol; 1993 Sep; 240(8):455-61. PubMed ID: 8263549
[TBL] [Abstract][Full Text] [Related]
35. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
[TBL] [Abstract][Full Text] [Related]
36. [Specificity of the dystrophin immunohistochemical technique in muscular dystrophy].
Colomer Oferil J; Vila Torres J; Huezo Montoya C
Neurologia; 1993 May; 8(5):112-5. PubMed ID: 8507503
[TBL] [Abstract][Full Text] [Related]
37. [Molecular genetics of Duchenne/Becker muscular dystrophy].
Saito K; Ikeya K; Kondo E; Yamauchi A; Komine S; Fukuyama Y
Nihon Rinsho; 1993 Sep; 51(9):2420-7. PubMed ID: 8411723
[TBL] [Abstract][Full Text] [Related]
38. Becker muscular dystrophy: detection of unusual disease courses by combined approach to dystrophin analysis.
Gold R; Kress W; Meurers B; Meng G; Reichmann H; Müller CR
Muscle Nerve; 1992 Feb; 15(2):214-8. PubMed ID: 1549142
[TBL] [Abstract][Full Text] [Related]
39. Sarcolemmal distribution of abnormal dystrophin in Xp21 carriers.
Vainzof M; Nicholson LV; Bulman DE; Tsanaclis AM; Passos-Bueno MR; Pavanello RC; Zatz M
Neuromuscul Disord; 1993 Mar; 3(2):135-40. PubMed ID: 7689380
[TBL] [Abstract][Full Text] [Related]
40. Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctions.
Beggs AH; Hoffman EP; Kunkel LM
Am J Med Genet; 1992 Oct; 44(3):378-81. PubMed ID: 1488990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
